Literature DB >> 8445336

Metabolism of molecular species of phosphatidylethanolamine and phosphatidylcholine in rat hepatocytes during prolonged inhibition of phosphatidylethanolamine N-methyltransferase.

R W Samborski1, N D Ridgway, D E Vance.   

Abstract

The metabolism of the molecular species of phosphatidylethanolamine (PE) and phosphatidylcholine (PC) derived from [3H]ethanolamine has been studied in rat hepatocytes during prolonged inhibition of phosphatidylethanolamine-N-methyltransferase (PEMT) with 3-deazaadenosine (DZA). After an initial pulse of radioactivity for 1 h and a chase for up to 24 h in the presence or absence of DZA, the cells were harvested and the incorporation of label into the various molecular species of PE and PC was determined. Prolonged inhibition of PEMT did not affect the mol% distribution of either PE or PC molecular species. Thus, PE methylation is not required for the maintenance of cellular PE and PC molecular species composition. While the overall catabolism of PE was not affected by DZA treatment, inhibition of PEMT resulted in the selective degradation of 16:0-22:6-PE. The major catabolic products of PE in the hepatocytes and the medium were glycerophosphoethanolamine and ethanolamine-phosphate. PC, derived from PE, was remodeled at both the sn-1 and sn-2 positions and this process was not affected by the inhibition of PEMT. The major species being remodeled was 16:0-22:6-PC. The rapid turnover of 16:0-22:6-PE and PC species compared to other PE and PC species may be due to the presence of a 16:0-22:6 selective phospholipase.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8445336

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  6 in total

1.  Dietary eritadenine-induced alteration of molecular species composition of phospholipids in rats.

Authors:  K Sugiyama; A Yamakawa
Journal:  Lipids       Date:  1996-04       Impact factor: 1.880

2.  Docosahexaenoic acid in plasma phosphatidylcholine may be a potential marker for in vivo phosphatidylethanolamine N-methyltransferase activity in humans.

Authors:  Kerry-Ann da Costa; Lisa M Sanders; Leslie M Fischer; Steven H Zeisel
Journal:  Am J Clin Nutr       Date:  2011-03-16       Impact factor: 7.045

3.  Generation and remodeling of highly polyunsaturated molecular species of rat hepatocyte phospholipids.

Authors:  P C Schmid; I Spimrova; H H Schmid
Journal:  Lipids       Date:  1997-11       Impact factor: 1.880

4.  Specificity and rate of human and mouse liver and plasma phosphatidylcholine synthesis analyzed in vivo.

Authors:  Christopher J Pynn; Neil G Henderson; Howard Clark; Grielof Koster; Wolfgang Bernhard; Anthony D Postle
Journal:  J Lipid Res       Date:  2010-11-10       Impact factor: 5.922

5.  Excess S-adenosylmethionine reroutes phosphatidylethanolamine towards phosphatidylcholine and triglyceride synthesis.

Authors:  Maite Martínez-Uña; Marta Varela-Rey; Ainara Cano; Larraitz Fernández-Ares; Naiara Beraza; Igor Aurrekoetxea; Ibon Martínez-Arranz; Juan L García-Rodríguez; Xabier Buqué; Daniela Mestre; Zigmund Luka; Conrad Wagner; Cristina Alonso; Richard H Finnell; Shelly C Lu; M Luz Martínez-Chantar; Patricia Aspichueta; José M Mato
Journal:  Hepatology       Date:  2013-08-14       Impact factor: 17.425

6.  Phospholipid methylation regulates muscle metabolic rate through Ca2+ transport efficiency.

Authors:  Anthony R P Verkerke; Patrick J Ferrara; Chien-Te Lin; Jordan M Johnson; Terence E Ryan; J Alan Maschek; Hiroaki Eshima; Christopher W Paran; Brenton T Laing; Piyarat Siripoksup; Trevor S Tippetts; Edward J Wentzler; Hu Huang; Espen E Spangenburg; Jeffrey J Brault; Claudio J Villanueva; Scott A Summers; William L Holland; James E Cox; Dennis E Vance; P Darrell Neufer; Katsuhiko Funai
Journal:  Nat Metab       Date:  2019-09-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.